Chubb Corp’s GSK GSK Stock Holding History

Chubb Corp’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$22.2M	Hold	440,000	–	–	1.79%	25
2015 Q3	$21.1M	Hold	440,000	–	–	1.22%	38
2015 Q2	$22.9M	Buy	440,000 +80,000	+22%	+$4.5M	1.19%	30
2015 Q1	$20.8M	Buy	360,000 +215,200	+149%	+$12.3M	1.08%	43
2014 Q4	$7.74M	Hold	144,800	–	–	0.4%	88
2014 Q3	$8.32M	Hold	144,800	–	–	0.45%	88
2014 Q2	$9.68M	Hold	144,800	–	–	0.5%	89
2014 Q1	$9.67M	Hold	144,800	–	–	0.53%	89
2013 Q4	$9.66M	Hold	144,800	–	–	0.54%	89
2013 Q3	$9.08M	Hold	144,800	–	–	0.5%	88
2013 Q2	$9.04M	Buy	+144,800	New	+$9.19M	0.49%	89

Other funds holding GSK

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hotchkis & Wiley Capital Management

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return